10-K Decoder · All companies

Viking Therapeutics, Inc.

VKTX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$0K$0K
Operating income−$393M−$151M−161%
Net income−$360M−$110M−227%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Oct 29, 2026

$Q3 2026Year earlierChange
Revenue$0K$0K
Operating income−$187M−$98.6M−89.8%
Net income−$183M−$90.8M−102%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Viking Therapeutics's revenue in FY2025?
$0K in FY2025 (Fiscal year ended Dec 31, 2025), no comparable figure vs $0K a year earlier, per its 10-K filed Feb 2026.
Was Viking Therapeutics profitable in FY2025?
No: net income was −$360M and operating income −$393M in FY2025.
What was Viking Therapeutics's revenue in Q3 2026?
$0K (n/a vs a year earlier), per its Form 10-Q filed Oct 29, 2026.